RetsemaJGirardASchelklyW, et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother. 1987;31(12):1939-1947. doi:10.1128/AAC.31.12.1939.
3.
LangtryHDBalfourJA.Azithromycin: a review of its use in paediatric infectious diseases. Drugs. 1998;56(2):273-297. doi:10.2165/00003495-199856020-00014.
4.
O’BrienKSEmersonPHooperPJ, et al. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review. Lancet Infect Dis. 2019;19(1):e14-e25. doi:10.1016/S1473-3099(18)30444-4.
5.
DeMuriGPSterkelAKKubicaPADusterMNReedKDWaldER.Macrolide and clindamycin resistance in group a streptococci isolated from children with pharyngitis. Pediatr Infect Dis J. 2017;36(3):342-344. doi:10.1097/INF.0000000000001442.
6.
OvetchkinePRiederMJ; Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee. Azithromycin use in paediatrics: a practical overview. Paediatr Child Health. 2013;18(6):311-316. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680256/.
ShulmanSTBisnoALCleggHW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86-e102. doi:10.1093/cid/cis629.
11.
LieberthalASCarrollAEChonmaitreeT, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964-e999. doi:10.1542/peds.2012-3488.
12.
BradleyJSByingtonCLShahSS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25-e76. doi:10.1093/cid/cir531.
13.
DaganRJohnsonCEMcLinnSAbughaliNFerisJLeibovitzE, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J. 2000;19(2):95-104. doi:10.1097/00006454-200002000-00002.
14.
ArguedasADaganRLeibovitzEHobermanAPichicheroMParisM.A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection. Pediatr Infect Dis J. 2006;25(3):211-218. doi:10.1097/01.inf.0000202138.12950.3c.
15.
MacyEPoonK-YT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med. 2009;122(8):778.e1-778.e7. doi:10.1016/j.amjmed.2009.01.034.
16.
BaxterMBethuneCPowellRMorganM.Point prevalence of penicillin allergy in hospital inpatients. J Hosp Infect. 2020;106(1):65-70. doi:10.1016/j.jhin.2020.06.016.
17.
LucasMArnoldASommerfieldATrevenenMBraconnierLSchillingA, et al. Antibiotic allergy labels in children are associated with adverse clinical outcomes. J Allergy Clin Immunol Pract. 2019;7(3):975-982. doi:10.1016/j.jaip.2018.09.003.
18.
MacFaddenDRLaDelfaALeenJ, et al. Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study. Clin Infect Dis. 2016;63(7):904-910. doi:10.1093/cid/ciw462.
19.
JoergerTTaylorMGLiYPalazziDLGerberJS.Impact of penicillin allergy labels on children treated for outpatient respiratory infections. J Pediatric Infect Dis Soc. 2023;12(2):92-98. doi:10.1093/jpids/piac125.
20.
TaylorMAnvariSPalazziD.Unconfirmed penicillin allergy labels in the paediatric outpatient setting: a call for research and quality improvement initiatives. J Paediatr Child Health. 2021;57(5):607-610. doi:10.1111/jpc.15445.
21.
SamarakoonUAccarinoJWurcelAGJaggersJJuddABlumenthalKG.Penicillin allergy delabeling: opportunities for implementation and dissemination. Ann Allergy Asthma Immunol. 2023;130(5):554-564. doi:10.1016/j.anai.2022.12.023.
22.
Centers for Disease Control Prevention. Core elements of hospital antibiotic stewardship programs. Washington, DC: US Department of Health and Human Services, Centers for Disease Control Prevention; 2019. Accessed January 5, 2022. https://www.cdc.gov/antibiotic-use/core-elements/hospital.html.
23.
SanchezGVFleming-DutraKERobertsRMHicksLA.Core elements of outpatient antibiotic stewardship. MMWR Recomm Rep. 2016;65(6):1-12. doi:10.15585/mmwr.rr6506a1.
24.
GhigaISidorchukAPitchforthEStålsby LundborgCMachowskaA.“If you want to go far, go together”—community-based behaviour change interventions to improve antibiotic use: a systematic review of quantitative and qualitative evidence. J Antimicrob Chemother. 2023;78(6):1344-1353. doi:10.1093/jac/dkad128.